Show simple item record

dc.contributor.authorBikkul, MU
dc.contributor.authorFaragher, RGA
dc.contributor.authorWorthington, G
dc.contributor.authorMeinke, P
dc.contributor.authorKerr, ARW
dc.contributor.authorSammy, A
dc.contributor.authorRiyahi, K
dc.contributor.authorHorton, D
dc.contributor.authorSchirmer, EC
dc.contributor.authorHubank, M
dc.contributor.authorKill, IR
dc.contributor.authorAnderson, RM
dc.contributor.authorSlijepcevic, P
dc.contributor.authorMakarov, E
dc.contributor.authorBridger, JM
dc.date.accessioned2019-03-26T15:48:28Z
dc.date.issued2019-06
dc.identifier.citationGenes, chromosomes & cancer, 2019, 58 (6), pp. 341 - 356
dc.identifier.issn1045-2257
dc.identifier.urihttps://repository.icr.ac.uk/handle/internal/3164
dc.identifier.eissn1098-2264
dc.identifier.doi10.1002/gcc.22711
dc.description.abstractImmortalizing primary cells with human telomerase reverse transcriptase (hTERT) has been common practice to enable primary cells to be of extended use in the laboratory because they avoid replicative senescence. Studying exogenously expressed hTERT in cells also affords scientists models of early carcinogenesis and telomere behavior. Control and the premature ageing disease-Hutchinson-Gilford progeria syndrome (HGPS) primary dermal fibroblasts, with and without the classical G608G mutation have been immortalized with exogenous hTERT. However, hTERT immortalization surprisingly elicits genome reorganization not only in disease cells but also in the normal control cells, such that whole chromosome territories normally located at the nuclear periphery in proliferating fibroblasts become mislocalized in the nuclear interior. This includes chromosome 18 in the control fibroblasts and both chromosomes 18 and X in HGPS cells, which physically express an isoform of the LINC complex protein SUN1 that has previously only been theoretical. Additionally, this HGPS cell line has also become genomically unstable and has a tetraploid karyotype, which could be due to the novel SUN1 isoform. Long-term treatment with the hTERT inhibitor BIBR1532 enabled the reduction of telomere length in the immortalized cells and resulted that these mislocalized internal chromosomes to be located at the nuclear periphery, as assessed in actively proliferating cells. Taken together, these findings reveal that elongated telomeres lead to dramatic chromosome mislocalization, which can be restored with a drug treatment that results in telomere reshortening and that a novel SUN1 isoform combined with elongated telomeres leads to genomic instability. Thus, care should be taken when interpreting data from genomic studies in hTERT-immortalized cell lines.
dc.formatPrint-Electronic
dc.format.extent341 - 356
dc.languageeng
dc.language.isoeng
dc.rights.urihttps://creativecommons.org/licenses/by/4.0
dc.subjectCells, Cultured
dc.subjectCell Line
dc.subjectFibroblasts
dc.subjectHumans
dc.subjectProgeria
dc.subjectGenomic Instability
dc.subjectTelomerase
dc.subjectMicrotubule-Associated Proteins
dc.subjectMembrane Proteins
dc.subjectNuclear Proteins
dc.subjectProtein Isoforms
dc.subjectTelomere Homeostasis
dc.subjectAbnormal Karyotype
dc.titleTelomere elongation through hTERT immortalization leads to chromosome repositioning in control cells and genomic instability in Hutchinson-Gilford progeria syndrome fibroblasts, expressing a novel SUN1 isoform.
dc.typeJournal Article
dcterms.dateAccepted2018-11-22
rioxxterms.versionofrecord10.1002/gcc.22711
rioxxterms.licenseref.urihttps://creativecommons.org/licenses/by-nc/4.0
rioxxterms.licenseref.startdate2019-06
rioxxterms.typeJournal Article/Review
dc.relation.isPartOfGenes, chromosomes & cancer
pubs.issue6
pubs.notesNo embargo
pubs.organisational-group/ICR
pubs.organisational-group/ICR/Primary Group
pubs.organisational-group/ICR/Primary Group/ICR Divisions
pubs.organisational-group/ICR/Primary Group/ICR Divisions/Molecular Pathology
pubs.organisational-group/ICR/Primary Group/ICR Divisions/Molecular Pathology/Translational Genomics
pubs.organisational-group/ICR/Primary Group/ICR Divisions/Molecular Pathology/Translational Genomics/Translational Genomics (hon.)
pubs.organisational-group/ICR
pubs.organisational-group/ICR/Primary Group
pubs.organisational-group/ICR/Primary Group/ICR Divisions
pubs.organisational-group/ICR/Primary Group/ICR Divisions/Molecular Pathology
pubs.organisational-group/ICR/Primary Group/ICR Divisions/Molecular Pathology/Translational Genomics
pubs.organisational-group/ICR/Primary Group/ICR Divisions/Molecular Pathology/Translational Genomics/Translational Genomics (hon.)
pubs.publication-statusPublished
pubs.volume58en_US
pubs.embargo.termsNo embargo
icr.researchteamTranslational Genomicsen_US
dc.contributor.icrauthorHubank, Michaelen


Files in this item

Thumbnail

This item appears in the following collection(s)

Show simple item record

https://creativecommons.org/licenses/by/4.0
Except where otherwise noted, this item's license is described as https://creativecommons.org/licenses/by/4.0